WKME vs. SVFCX, INST, TDC, BL, AI, MQ, CERT, ALKT, INTA, and YOU
Should you be buying WalkMe stock or one of its competitors? The main competitors of WalkMe include Smead Value C (SVFCX), Instructure (INST), Teradata (TDC), BlackLine (BL), C3.ai (AI), Marqeta (MQ), Certara (CERT), Alkami Technology (ALKT), Intapp (INTA), and Clear Secure (YOU).
Smead Value C (NASDAQ:SVFCX) and WalkMe (NASDAQ:WKME) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, community ranking, dividends, media sentiment and analyst recommendations.
Smead Value C has a beta of 0.11, suggesting that its stock price is 89% less volatile than the S&P 500. Comparatively, WalkMe has a beta of -0.1, suggesting that its stock price is 110% less volatile than the S&P 500.
WalkMe received 31 more outperform votes than Smead Value C when rated by MarketBeat users. However, 100.00% of users gave Smead Value C an outperform vote while only 42.31% of users gave WalkMe an outperform vote.
60.2% of Smead Value C shares are held by institutional investors. Comparatively, 70.9% of WalkMe shares are held by institutional investors. 10.3% of Smead Value C shares are held by insiders. Comparatively, 27.6% of WalkMe shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Smead Value C has a net margin of 0.00% compared to Smead Value C's net margin of -14.52%. WalkMe's return on equity of 0.00% beat Smead Value C's return on equity.
Smead Value C has higher earnings, but lower revenue than WalkMe.
WalkMe has a consensus target price of $12.86, indicating a potential upside of 41.29%. Given Smead Value C's higher possible upside, analysts clearly believe WalkMe is more favorable than Smead Value C.
In the previous week, WalkMe had 5 more articles in the media than Smead Value C. MarketBeat recorded 5 mentions for WalkMe and 0 mentions for Smead Value C. Smead Value C's average media sentiment score of 0.91 beat WalkMe's score of 0.00 indicating that WalkMe is being referred to more favorably in the news media.
Summary
WalkMe beats Smead Value C on 9 of the 14 factors compared between the two stocks.
Get WalkMe News Delivered to You Automatically
Sign up to receive the latest news and ratings for WKME and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding WKME and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
